1
GSK PLC
SPONSORED ADR
GSK
GSK
3,468,080
$133.5m10.22%
10.22%
Reduced Shares held: Q3 2023 3.3m, Q4 2023 3.0m, Q1 2024 3.8m, Q2 2024 3.5m
-303.9k
-303,914
-8.1%
2
NATERA INC
COM
NTRA
NTRA
1,173,494
$127.1m9.73%
9.73%
Reduced Shares held: Q3 2023 2.5m, Q4 2023 2.3m, Q1 2024 1.8m, Q2 2024 1.2m
-604.6k
-604,557
-34.0%
3
INSMED INC
COM PAR $.01
INSM
INSM
1,155,588
$77.4m5.93%
5.93%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.2m
4
TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADS
SPONSORED ADS
4,720,460
$76.7m5.87%
5.87%
Reduced Shares held: Q3 2023 7.0m, Q4 2023 6.2m, Q1 2024 6.0m, Q2 2024 4.7m
-1.3m
-1,304,709
-21.6%
5
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
235,351
$75.0m5.74%
5.74%
Reduced Shares held: Q3 2023 267.9k, Q4 2023 246.2k, Q1 2024 251.1k, Q2 2024 235.4k
-15.8k
-15,784
-6.3%
6
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
3,613,631
$74.2m5.68%
5.68%
Added Shares held: Q3 2023 2.6m, Q4 2023 3.4m, Q1 2024 3.1m, Q2 2024 3.6m
+480.5k
+480,518
15.3%
7
VERA THERAPEUTICS INC
CL A
VERA
VERA
2,043,214
$73.9m5.66%
5.66%
Added Shares held: Q3 2023 1.5m, Q4 2023 1.9m, Q1 2024 1.8m, Q2 2024 2.0m
+219.4k
+219,433
12.0%
8
INSPIRE MED SYS INC
COM
INSP
INSP
533,011
$71.3m5.46%
5.46%
Added Shares held: Q3 2023 193.0k, Q4 2023 351.1k, Q1 2024 420.7k, Q2 2024 533.0k
+112.3k
+112,312
26.7%
9
REVVITY INC
COM
RVTY
RVTY
451,582
$47.4m3.62%
3.62%
Reduced Shares held: Q3 2023 32.7k, Q4 2023 183.1k, Q1 2024 483.2k, Q2 2024 451.6k
-31.6k
-31,578
-6.5%
10
HCA HEALTHCARE INC
COM
HCA
HCA
135,480
$43.5m3.33%
3.33%
Added Shares held: Q3 2023 110.1k, Q4 2023 114.8k, Q1 2024 103.8k, Q2 2024 135.5k
+31.7k
+31,659
30.5%
11
BIO-TECHNE CORP
COM
TECH
TECH
543,044
$38.9m2.98%
2.98%
Reduced Shares held: Q3 2023 385.9k, Q4 2023 465.3k, Q1 2024 607.7k, Q2 2024 543.0k
-64.6k
-64,643
-10.6%
12
HEALTHEQUITY INC
COM
HQY
HQY
413,531
$35.6m2.73%
2.73%
Reduced Shares held: Q3 2023 338.5k, Q4 2023 494.9k, Q1 2024 421.3k, Q2 2024 413.5k
-7.8k
-7,814
-1.9%
13
COMMUNITY HEALTH SYS INC NEW
COM
CYH
CYH
8,037,470
$27.0m2.07%
2.07%
Added Shares held: Q3 2023 7.1m, Q4 2023 7.2m, Q1 2024 8.0m, Q2 2024 8.0m
+56.8k
+56,829
0.7%
14
REPLIGEN CORP
COM
RGEN
RGEN
194,291
$24.5m1.87%
1.87%
Added Shares held: Q3 2023 16.2k, Q4 2023 10.0k, Q1 2024 8.2k, Q2 2024 194.3k
+186.1k
+186,054
2258.8%
15
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
633,015
$23.4m1.79%
1.79%
Reduced Shares held: Q3 2023 588.1k, Q4 2023 754.1k, Q1 2024 711.1k, Q2 2024 633.0k
-78.1k
-78,100
-11.0%
16
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
456,881
$21.8m1.67%
1.67%
Added Shares held: Q3 2023 252.4k, Q4 2023 324.7k, Q1 2024 376.4k, Q2 2024 456.9k
+80.4k
+80,443
21.4%
17
NOVO-NORDISK A S
ADR
NVO
NVO
146,956
$21.0m1.61%
1.61%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 62.3k, Q2 2024 147.0k
+84.6k
+84,612
135.7%
18
ELI LILLY & CO
COM
LLY
LLY
21,233
$19.2m1.47%
1.47%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 12.9k, Q2 2024 21.2k
+8.4k
+8,356
64.9%
19
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
505,836
$17.5m1.34%
1.34%
Added Shares held: Q3 2023 286.7k, Q4 2023 538.1k, Q1 2024 411.5k, Q2 2024 505.8k
+94.4k
+94,358
22.9%
20
ARGENX SE
SPONSORED ADR
ARGX
ARGX
34,593
$14.9m1.14%
1.14%
Reduced Shares held: Q3 2023 4.6k, Q4 2023 85.8k, Q1 2024 54.5k, Q2 2024 34.6k
-19.9k
-19,925
-36.5%
21
HUMANA INC
COM
HUM
HUM
38,023
$14.2m1.09%
1.09%
Added Shares held: Q3 2023 18.1k, Q4 2023 1.9k, Q1 2024 35.5k, Q2 2024 38.0k
+2.5k
+2,491
7.0%
22
VIATRIS INC
COM
VTRS
VTRS
1,329,282
$14.1m1.08%
1.08%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.3m, Q2 2024 1.3m
+12.8k
+12,813
1.0%
23
ZIMVIE INC
COM
ZIMV
ZIMV
767,659
$14.0m1.07%
1.07%
Added Shares held: Q3 2023 0, Q4 2023 546.4k, Q1 2024 564.5k, Q2 2024 767.7k
+203.2k
+203,161
36.0%
24
MANNKIND CORP
COM NEW
MNKD
MNKD
2,256,952
$11.8m0.90%
0.90%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.4m, Q2 2024 2.3m
-134.2k
-134,176
-5.6%
25
BROOKDALE SR LIVING INC
COM
BKD
BKD
1,546,842
$10.6m0.81%
0.81%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.3m, Q2 2024 1.5m
+228.1k
+228,077
17.3%
26
DANAHER CORPORATION
COM
DHR
DHR
40,855
$10.2m0.78%
0.78%
Unchanged Shares held: Q3 2023 103.8k, Q4 2023 41.0k, Q1 2024 40.9k, Q2 2024 40.9k
27
SPDR SER TR
S&P BIOTECH
XBI
XBI
100,000
$9.3m0.71%
0.71%
New Shares held: Q3 2023 20.0k, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
28
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
1,091,165
$9.0m0.69%
0.69%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 955.6k, Q2 2024 1.1m
+135.5k
+135,547
14.2%
29
ELEVANCE HEALTH INC
COM
ELV
ELV
14,657
$7.9m0.61%
0.61%
Added Shares held: Q3 2023 21.7k, Q4 2023 15.1k, Q1 2024 14.4k, Q2 2024 14.7k
+264
+264
1.8%
30
ARCUTIS BIOTHERAPEUTICS INC
COM
ARQT
ARQT
837,847
$7.8m0.60%
0.60%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 837.8k
31
CENTENE CORP DEL
COM
CNC
CNC
115,820
$7.7m0.59%
0.59%
Added Shares held: Q3 2023 190.6k, Q4 2023 97.2k, Q1 2024 92.8k, Q2 2024 115.8k
+23.0k
+23,034
24.8%
32
VIRIDIAN THERAPEUTICS INC
COM
VRDN
VRDN
567,487
$7.4m0.57%
0.57%
Added Shares held: Q3 2023 443.3k, Q4 2023 137.3k, Q1 2024 142.1k, Q2 2024 567.5k
+425.4k
+425,412
299.4%
33
VIKING THERAPEUTICS INC
COM
VKTX
VKTX
138,489
$7.3m0.56%
0.56%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 22.8k, Q2 2024 138.5k
+115.7k
+115,671
506.9%
34
VAXCYTE INC
COM
PCVX
PCVX
96,089
$7.3m0.56%
0.56%
Reduced Shares held: Q3 2023 190.4k, Q4 2023 233.8k, Q1 2024 197.3k, Q2 2024 96.1k
-101.2k
-101,242
-51.3%
35
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
1,152,573
$7.1m0.55%
0.55%
Reduced Shares held: Q3 2023 2.5m, Q4 2023 1.5m, Q1 2024 1.4m, Q2 2024 1.2m
-279.9k
-279,854
-19.5%
36
CYTOKINETICS INC
COM NEW
CYTK
CYTK
126,877
$6.9m0.53%
0.53%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 126.9k
37
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
NAMS
NAMS
329,890
$6.3m0.48%
0.48%
Reduced Shares held: Q3 2023 660.6k, Q4 2023 374.4k, Q1 2024 354.0k, Q2 2024 329.9k
-24.1k
-24,075
-6.8%
38
EVOLUS INC
COM
EOLS
EOLS
574,462
$6.2m0.48%
0.48%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 574.5k
39
MOLINA HEALTHCARE INC
COM
MOH
MOH
18,277
$5.4m0.42%
0.42%
Added Shares held: Q3 2023 12.2k, Q4 2023 6.1k, Q1 2024 5.8k, Q2 2024 18.3k
+12.4k
+12,449
213.6%
40
SUTRO BIOPHARMA INC
COM
COM
1,739,129
$5.1m0.39%
0.39%
Added Shares held: Q3 2023 769.6k, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 1.7m
+647.7k
+647,710
59.4%
41
GOSSAMER BIO INC
COM
GOSS
GOSS
5,484,148
$4.9m0.38%
0.38%
Reduced Shares held: Q3 2023 4.4m, Q4 2023 6.4m, Q1 2024 6.0m, Q2 2024 5.5m
-510.3k
-510,324
-8.5%
42
OSCAR HEALTH INC
CL A
OSCR
OSCR
310,893
$4.9m0.38%
0.38%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 310.9k
43
CEREVEL THERAPEUTICS HLDNG I
COM
CERE
CERE
110,010
$4.5m0.34%
0.34%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 110.0k
44
LIQUIDIA CORPORATION
COM NEW
LQDA
LQDA
373,554
$4.5m0.34%
0.34%
Reduced Shares held: Q3 2023 1.4m, Q4 2023 688.9k, Q1 2024 396.2k, Q2 2024 373.6k
-22.6k
-22,633
-5.7%
45
MYRIAD GENETICS INC
COM
MYGN
MYGN
181,961
$4.5m0.34%
0.34%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 182.0k
46
PUMA BIOTECHNOLOGY INC
COM
PBYI
PBYI
1,328,454
$4.3m0.33%
0.33%
Reduced Shares held: Q3 2023 1.7m, Q4 2023 1.7m, Q1 2024 1.4m, Q2 2024 1.3m
-98.0k
-98,043
-6.9%
47
KARYOPHARM THERAPEUTICS INC
COM
COM
4,987,180
$4.3m0.33%
0.33%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 5.0m, Q2 2024 5.0m
-29.1k
-29,140
-0.6%
48
2SEVENTY BIO INC
COMMON STOCK
TSVT
TSVT
1,107,743
$4.3m0.33%
0.33%
Reduced Shares held: Q3 2023 1.5m, Q4 2023 1.1m, Q1 2024 1.2m, Q2 2024 1.1m
-69.9k
-69,935
-5.9%
49
NEVRO CORP
COM
NVRO
NVRO
499,395
$4.2m0.32%
0.32%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 389.7k, Q2 2024 499.4k
+109.7k
+109,732
28.2%
50
ICON PLC
SHS
ICLR
ICLR
12,642
$4.0m0.30%
0.30%
Reduced Shares held: Q3 2023 21.0k, Q4 2023 15.4k, Q1 2024 15.3k, Q2 2024 12.6k
-2.7k
-2,705
-17.6%
51
MERUS N V
COM
MRUS
MRUS
66,474
$3.9m0.30%
0.30%
Reduced Shares held: Q3 2023 134.0k, Q4 2023 115.7k, Q1 2024 119.5k, Q2 2024 66.5k
-53.0k
-53,008
-44.4%
52
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
MLTX
MLTX
71,596
$3.1m0.24%
0.24%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 71.6k
53
AMARIN CORP PLC
SPONS ADR NEW
SPONS ADR NEW
4,308,527
$3.0m0.23%
0.23%
Reduced Shares held: Q3 2023 8.4m, Q4 2023 6.1m, Q1 2024 6.2m, Q2 2024 4.3m
-1.9m
-1,904,221
-30.6%
54
GUARDANT HEALTH INC
COM
GH
GH
99,377
$2.9m0.22%
0.22%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 449.6k, Q2 2024 99.4k
-350.2k
-350,209
-77.9%
55
INFLARX NV
COM
IFRX
IFRX
1,566,930
$2.7m0.21%
0.21%
Added Shares held: Q3 2023 1.7m, Q4 2023 1.3m, Q1 2024 1.3m, Q2 2024 1.6m
+261.8k
+261,790
20.1%
56
AVANTOR INC
COM
AVTR
AVTR
125,394
$2.7m0.20%
0.20%
Unchanged Shares held: Q3 2023 84.5k, Q4 2023 126.0k, Q1 2024 125.4k, Q2 2024 125.4k
57
TOURMALINE BIO INC
COM
TRML
TRML
204,781
$2.6m0.20%
0.20%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 204.8k
58
IQVIA HLDGS INC
COM
IQV
IQV
12,178
$2.6m0.20%
0.20%
Unchanged Shares held: Q3 2023 23.0k, Q4 2023 12.3k, Q1 2024 12.2k, Q2 2024 12.2k
59
ALECTOR INC
COM
ALEC
ALEC
541,739
$2.5m0.19%
0.19%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 536.2k, Q2 2024 541.7k
+5.6k
+5,568
1.0%
60
IMMUNOVANT INC
COM
IMVT
IMVT
92,909
$2.5m0.19%
0.19%
Reduced Shares held: Q3 2023 0, Q4 2023 113.8k, Q1 2024 255.5k, Q2 2024 92.9k
-162.6k
-162,617
-63.6%
61
XOMA ROYALTY CORPORATION
COM NEW
XOMA
XOMA
91,907
$2.2m0.17%
0.17%
Reduced Shares held: Q3 2023 90.0k, Q4 2023 93.7k, Q1 2024 97.1k, Q2 2024 91.9k
-5.2k
-5,158
-5.3%
62
AUTOLUS THERAPEUTICS PLC
SPON ADS
AUTL
AUTL
610,902
$2.1m0.16%
0.16%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 610.9k
63
TERNS PHARMACEUTICALS INC
COM
COM
286,266
$1.9m0.15%
0.15%
Added Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 283.0k, Q2 2024 286.3k
+3.2k
+3,232
1.1%
64
MEREO BIOPHARMA GROUP PLC
SPON ADS
MREO
MREO
496,171
$1.8m0.14%
0.14%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 496.2k
65
KURA ONCOLOGY INC
COM
KURA
KURA
72,317
$1.5m0.11%
0.11%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 72.3k
66
ABSCI CORPORATION
COM
ABSI
ABSI
325,509
$1.0m0.08%
0.08%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 325.5k
67
FULCRUM THERAPEUTICS INC
COM
FULC
FULC
152,965
$948.4k0.07%
0.07%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 153.0k
68
AFFIMED N V
ORDINARY SHS NEW
AFMDQ
AFMDQ
166,460
$907.2k0.07%
0.07%
Unchanged Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 166.5k, Q2 2024 166.5k
69
STOKE THERAPEUTICS INC
COM
STOK
STOK
61,277
$827.9k0.06%
0.06%
Reduced Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 290.0k, Q2 2024 61.3k
-228.7k
-228,723
-78.9%
70
G1 THERAPEUTICS INC
COM
GTHX
GTHX
199,963
$455.9k0.03%
0.03%
New Shares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 200.0k
71
AC IMMUNE SA
SHS
ACIU
ACIU
99,313
$396.3k0.03%
0.03%
Reduced Shares held: Q3 2023 124.6k, Q4 2023 124.6k, Q1 2024 124.6k, Q2 2024 99.3k
-25.3k
-25,276
-20.3%
72
SERES THERAPEUTICS INC
COM
COM
418,208
$302.7k0.02%
0.02%
Reduced Shares held: Q3 2023 2.4m, Q4 2023 1.8m, Q1 2024 1.4m, Q2 2024 418.2k
-970.7k
-970,736
-69.9%